The Cancer Genetics, Epigenetics, Models, & Signaling (GEMS T32) Training Program is a robust two-year predoctoral training program that leverages existing Huntsman Cancer Institute research and infrastructure strengths in cancer genetics and epigenetics, cancer modeling, and cancer cell signaling. The program integrates trainee interactions with cancer patients, cancer clinicians, and our Disease Centers to provide broad multidisciplinary training in cancer biology.
Program Goal
Prepare young scientists who are broadly trained in cancer biology and well-versed in multidisciplinary research for exciting, impactful, and rewarding opportunities in cancer-focused post-doctoral fellowships or other cancer-related, research-intensive careers.
Focus Areas
- Cancer genetics & epigenetics
- Models to study cancer
- Cell signaling
For more information, contact the principal investigators.
Accepts
Predoctoral Only
Applications Due
July (annually)
Principal Investigators
Donald E. Ayer, PhD
Sheri L. Holmen, PhD
